Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Doctor in the house? Your opinion? If/when I take

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155000
(Total Views: 651)
Posted On: 02/05/2021 6:55:04 PM
Posted By: smurph
Doctor in the house? Your opinion?
If/when I take vaccine -
It will NOT be any of the mRNA types out now: "Once inside your cells, the mRNA instructs your cells’ protein factories to make copies of these viral proteins. These then stimulate your immune system to mount a protective immune response. Too new, law of unintendeds

Novavax is not mRNA, but much closer to traditional.

"The Novavax vaccine, NVX-CoV2373, contains purified pieces of the spike protein of SARS-CoV-2, the virus that causes COVID-19. These proteins are administered with an adjuvant, a molecule that enhances the immune response.

"Early clinical trials were performed in Australia. In the phase 1 clinical trials, the vaccine was generally well-tolerated and produced strong antibody responses, stronger than what we see in patients recovering from COVID-19.

Results should be out soon: "In September, Novavax launched a phase 3 clinical trial in the United Kingdom. Further large-scale clinical trials are planned for other countries in late 2020 and early 2021.

https://theconversation.com/what-do-we-know-a...for-149522
*********************
"Jan. 29 after the company said its coronavirus vaccine was 89.3% effective in a Phase 3 test.

"Also bullish, the experimental drug was 95.6% effective at blocking the original strain and 85.6% effective against the mutated U.K. strain. It was also 60% effective in preventing Covid-19 resulting from the South Africa variant.

"Novavax's drug also outperformed experimental vaccines from Johnson & Johnson (JNJ) and AstraZeneca (AZN)

"Novavax's technology uses moth cells to develop molecules for vaccine development at a faster rate than the typical process, which relies on chicken eggs.

TIA.

"Hey, Fauci! How was your trip to Wuhan?"


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us